EnteraSense Limited
We are dedicated to adding value to the management and diagnosis of Upper GI bleeding hence improving patient outcomes. EnteraSense Limited is a medical device sensor diagnostic company founded in 2015 by Donal Devery, Dr. Chris Thompson of Brigham and Women’s Hospital/Harvard Medical School and Dr. Marvin Ryou of Brigham and Women’s Hospital in the United States. The company is based in Galway, Ireland and has a licensed technology agreement from Brigham and Women’s Hospital/Harvard Medical School which enables the company to develop devices for diagnosing and monitoring Upper Gastric Bleeds. EnteraSense raises an initial seed funding round of €1m.
Company details
Find locations served, office locations
- Business Type:
- Manufacturer
- Industry Type:
- Medical Equipment
- Market Focus:
- Nationally (across the country)
- Year Founded:
- 2015
About Us
Based in Galway, Ireland we have a licensed technology agreement from Brigham and Women’s Hospital/Harvard Medical School which enables us to develop ground-breaking devices for diagnosing and monitoring Upper Gastric Bleeds.
EnteraSense is a Medical Device company committed to the innovation and commercialisation of GI sensor technologies. We aim to transform and add value to the diagnosis and monitoring of Upper Gastrointestinal bleeding. We are dedicated to improving patient outcomes by allowing a quicker and more accurate diagnosis.